Unsure About the COVID-19 Vaccine? UF Health’s Chief Epidemiologist Has Answers
Nicole M. Iovine, M.D., Ph.D., chief epidemiology officer for the University of Florida Health Shands Hospital system, addresses key issues related to overcoming vaccine hesitancy.
Free Tech Support for Low-Income Seniors Navigating Vaccine Registration
Orchard introduced a free assistance to low-income older adults to help them with the vaccine signup process.
SARS-CoV-2 Spike Protein Licensed by Oragenics From the NIH Demonstrates Protective Immunity in Mice
UF startup and UF Innovate | Sid Martin Biotech graduate company Oragenics, Inc., a leader in the development of new antibiotics against infectious diseases and effective treatments for oral mucositis, announces that the stabilized pre-fusion spike protein CoV-2 S-2P created by the National Institutes of Health (“NIH”) and licensed by the Company demonstrates protective immunity in immunized mice challenged with mouse-adapted SARS-CoV-2 virus.
UF Health Pilot Program To Deliver COVID-19 Monoclonal Antibody Therapy to Rural Communities
A University of Florida Health pilot program will bring a new COVID-19 monoclonal antibody therapy to rural communities in North Florida.
UF Health Discovers Possible Risk Factor for COVID-19
A UF research team found vitamin D-deficient patients were four times more likely to be COVID-19 positive than those with a sufficient amount of the crucial vitamin, which people can get from sources like sunlight and animal proteins.
UF Researchers Create VR App To Help Medical Professionals De-Stress
Researchers at the University of Florida have created virtual reality (VR) software to help medical professionals de-stress from the demands of work and the pandemic.
Two-Drug Combo Shows Dramatic Results for COVID-19 Patients, UF Health Researchers Find
Combining an anti-inflammatory drug with an antiviral drug reduces recovery time and accelerates improvement for COVID-19 patients, a national study co-authored by UF Health researchers has found.
Two-Drug Combo Shows Dramatic Results for COVID-19 Patients, UF Health Researchers Find
Combining an anti-inflammatory drug with an antiviral drug reduces recovery time and accelerates improvement for COVID-19 patients, a national study co-authored by UF Health researchers has found.
UF Health Researcher Answers Top Questions About the New COVID-19 Vaccines
The leading COVID-19 vaccines aren’t anything like the polio vaccination your grandparents received — or even the flu shot you got this fall. A look under the hood unveils a remarkable advancement in medicine.
Tapeworm, Vertigo and Pancreatitis Drugs Are Being Trialled As COVID-19 Treatments
Included in this news roundup is UF startup Algernon Pharmaceuticals's trials with ifenprodil, a drug used to treat vertigo and bird flu. Algernon is testing the drug's efficacy in preventing lung damage and increasing survivability in patients with COVID-19.